Correlation Between Elevation Oncology and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Zura Bio Limited, you can compare the effects of market volatilities on Elevation Oncology and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Zura Bio.
Diversification Opportunities for Elevation Oncology and Zura Bio
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Elevation and Zura is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Zura Bio go up and down completely randomly.
Pair Corralation between Elevation Oncology and Zura Bio
Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.63 times more return on investment than Zura Bio. However, Elevation Oncology is 1.59 times less risky than Zura Bio. It trades about 0.04 of its potential returns per unit of risk. Zura Bio Limited is currently generating about 0.02 per unit of risk. If you would invest 92.00 in Elevation Oncology on August 27, 2024 and sell it today you would lose (32.00) from holding Elevation Oncology or give up 34.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 85.89% |
| Values | Daily Returns |
Elevation Oncology vs. Zura Bio Limited
Performance |
| Timeline |
| Elevation Oncology |
| Zura Bio Limited |
Elevation Oncology and Zura Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and Zura Bio
The main advantage of trading using opposite Elevation Oncology and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
| Zura Bio vs. Eliem Therapeutics | Zura Bio vs. HCW Biologics | Zura Bio vs. Scpharmaceuticals | Zura Bio vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |